Homo sapiens Protein: KRAS | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||||||||||||||
InnateDB Protein | IDBP-23893.7 | ||||||||||||||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||||||||||||
Gene Symbol | KRAS | ||||||||||||||||||||||||||||||||||||
Protein Name | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | ||||||||||||||||||||||||||||||||||||
Synonyms | C-K-RAS; CFC2; K-RAS2A; K-RAS2B; K-RAS4A; K-RAS4B; KI-RAS; KRAS1; KRAS2; NS; NS3; RASK2; | ||||||||||||||||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||||||||||||||||
Ensembl Protein | ENSP00000308495 | ||||||||||||||||||||||||||||||||||||
InnateDB Gene | IDBG-23889 (KRAS) | ||||||||||||||||||||||||||||||||||||
Protein Structure | |||||||||||||||||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||||||||||||||||
Function | Ras proteins bind GDP/GTP and possess intrinsic GTPase activity. | ||||||||||||||||||||||||||||||||||||
Subcellular Localization | Cell membrane; Lipid-anchor; Cytoplasmic side. | ||||||||||||||||||||||||||||||||||||
Disease Associations | Leukemia, acute myelogenous (AML) [MIM:601626]: A subtype of acute leukemia, a cancer of the white blood cells. AML is a malignant disease of bone marrow characterized by maturational arrest of hematopoietic precursors at an early stage of development. Clonal expansion of myeloid blasts occurs in bone marrow, blood, and other tissue. Myelogenous leukemias develop from changes in cells that normally produce neutrophils, basophils, eosinophils and monocytes. {ECO:0000269PubMed:8955068}. Note=The disease is caused by mutations affecting the gene represented in this entry.Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. Note=The disease is caused by mutations affecting the gene represented in this entry.Noonan syndrome 3 (NS3) [MIM:609942]: A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells. {ECO:0000269PubMed:16474405, ECO:0000269PubMed:16773572, ECO:0000269PubMed:17056636, ECO:0000269PubMed:17468812, ECO:0000269PubMed:19396835}. Note=The disease is caused by mutations affecting the gene represented in this entry.Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. {ECO:0000269PubMed:14534542, ECO:0000269PubMed:3034404, ECO:0000269PubMed:7773929}. Note=The disease is caused by mutations affecting the gene represented in this entry.Note=Defects in KRAS are a cause of pylocytic astrocytoma (PA). Pylocytic astrocytomas are neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors.Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278]: A form of cardiofaciocutaneous syndrome, a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. CFC2 patients often do not have the skin abnormalities, such as ichthyosis, hyperkeratosis, and hemangioma observed in CFC1. {ECO:0000269PubMed:16474404, ECO:0000269PubMed:16474405, ECO:0000269PubMed:17056636, ECO:0000269PubMed:21797849}. Note=The disease is caused by mutations affecting the gene represented in this entry.Note=KRAS mutations are involved in cancer development. | ||||||||||||||||||||||||||||||||||||
Tissue Specificity | |||||||||||||||||||||||||||||||||||||
Comments | |||||||||||||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 61 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||||||||||||||||
InterPro |
IPR000795
Elongation factor, GTP-binding domain IPR001806 Small GTPase superfamily IPR003578 Small GTPase superfamily, Rho type IPR003579 Small GTPase superfamily, Rab type IPR005225 Small GTP-binding protein domain IPR006689 Small GTPase superfamily, ARF/SAR type IPR013684 Mitochondrial Rho-like IPR020849 Small GTPase superfamily, Ras type IPR027417 P-loop containing nucleoside triphosphate hydrolase |
||||||||||||||||||||||||||||||||||||
PFAM |
PF00009
PF00071 PF00025 PF08477 |
||||||||||||||||||||||||||||||||||||
PRINTS |
PR00315
PR00449 PR00328 |
||||||||||||||||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||||||||||||||||
SMART |
SM00174
SM00175 SM00173 |
||||||||||||||||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||||||||||||||||
Modification | |||||||||||||||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||||||||||||||
SwissProt | P01116 | ||||||||||||||||||||||||||||||||||||
PhosphoSite | PhosphoSite-P01116 | ||||||||||||||||||||||||||||||||||||
TrEMBL | Q9UM97 | ||||||||||||||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||||||||||||||
Entrez Gene | 3845 | ||||||||||||||||||||||||||||||||||||
UniGene | Hs.734869 | ||||||||||||||||||||||||||||||||||||
RefSeq | NP_004976 | ||||||||||||||||||||||||||||||||||||
HUGO | HGNC:6407 | ||||||||||||||||||||||||||||||||||||
OMIM | 190070 | ||||||||||||||||||||||||||||||||||||
CCDS | CCDS8702 | ||||||||||||||||||||||||||||||||||||
HPRD | 01817 | ||||||||||||||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||||||||||||||
EMBL | AF285779 AF493917 AK292510 BC013572 BT007153 CH471094 EF685661 EF685662 EU332849 JQ248012 K01519 K01520 K03209 K03210 L00045 L00046 L00047 L00048 L00049 M19990 M25876 M30539 M34904 M54968 S68580 X01669 X02825 | ||||||||||||||||||||||||||||||||||||
GenPept | AAA35683 AAA36149 AAA36554 AAA36557 AAA52693 AAB29639 AAB41942 AAB59444 AAB59445 AAF91482 AAH13572 AAM12631 AAP35817 ABS10683 ABS10684 ABY87538 AFF18187 BAF85199 CAA25828 CAA26593 EAW96511 EAW96512 EAW96513 | ||||||||||||||||||||||||||||||||||||